BioScrip Inc  

(Public, NASDAQ:BIOS)   Watch this stock  
Find more results for BIOS
5.92
-0.07 (-1.17%)
Feb 26 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 5.86 - 6.05
52 week 5.26 - 8.75
Open 6.00
Vol / Avg. 0.00/727,766.00
Mkt cap 406.33M
P/E     -
Div/yield     -
EPS -1.41
Shares 68.64M
Beta 0.77
Inst. own 97%
Feb 27, 2015
Q4 2014 BioScrip Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Dec 3, 2014
BioScrip Inc at Bank of America Merrill Lynch Leveraged Finance Conference
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin -15.40% -6.37%
Operating margin -10.69% -2.72%
EBITD margin - 4.41%
Return on average assets -17.30% -6.79%
Return on average equity -50.78% -16.55%
Employees 2,893 -
CDP Score - -

Address

100 Clearbrook Rd
ELMSFORD, NY 10523-1116
United States - Map
+1-914-4601600 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

BioScrip, Inc. provides home infusion and other home healthcare services. The Company�s services are designed to improve clinical outcomes for patients with chronic and acute healthcare conditions while controlling overall healthcare costs. The Company�s platform provides nationwide service capabilities and the ability to deliver clinical management services that offer patients a high-touch, home-based and community-based care environment. Its core services are provided in coordination with, and under the direction of the patients' physicians. The Company�s multidisciplinary team of clinicians, including pharmacists, nurses, dietitians, respiratory therapists and physical therapists, work with the physician to develop a plan of care suited to its patients� specific needs. In February 2013, the Company acquired 100% of the ownership interest in HomeChoice Partners, Inc., a Delaware corporation (HomeChoice). HomeChoice is a provider of alternate-site infusion pharmacy services.

Officers and directors

Myron Z. Holubiak Independent Chairman of the Board
Age: 74
Bio & Compensation  - Reuters
Richard M. Smith President, Chief Executive Officer, Director
Age: 54
Bio & Compensation  - Reuters
Hai V. Tran Chief Financial Officer, Treasurer
Age: 44
Bio & Compensation  - Reuters
Thomas F. Pettit Chief Operating Officer, Senior Vice President
Age: 45
Bio & Compensation  - Reuters
Brian Stiver Senior Vice President - National Infusion Sales
Age: 51
Bio & Compensation  - Reuters
Vito Ponzio Jr. Senior Vice President - Human Resources
Age: 59
Bio & Compensation  - Reuters
David Evans Senior Vice President - Strategic Operations
Age: 50
Bio & Compensation  - Reuters
Barbara Cormier Chief Compliance Officer and Privacy Officer
Age: 71
Bio & Compensation  - Reuters
Patricia Bogusz Vice President - Finance, Principal Accounting Officer
Age: 54
Bio & Compensation  - Reuters
Daniel Colucci Vice President - PBM Services
Age: 49
Bio & Compensation  - Reuters